Skip to Main Content
About Us
Back
High Science High Touch
The Wheeler Team
Board of Directors
Biologics
Back
mAbs
Multispecifics
Fusion Proteins
ADCs
CDMO Services
Back
ModularCMC™
Wheeler Bio's ModularCMC™ services empower clients to navigate the complex biologics landscape with ease.
View All CMC Modules
Program Types
Lead Selection
Cell Line Development
Rapid Tox Supply
Traditional Tox Supply
Lead to Clinic
CMC Development Services
Cell Line Development
Process Development & Optimization
Analytical Development & Qualification
Formulation Development
Manufacturing Services
Master Cell Banking
Drug Substance Manufacturing
Drug Product Manufacturing
Partnered Services
Lead Optimization
Regulatory Support
Fill Finish
News & Media
Careers
Contact
News & Resources
Podcast: From Development to Manufacturing in Biologics
Resources
June 6, 2023
Share
Related Posts
View All
News + PR
OU–Industry Collaboration Harnesses AI to Accelerate Antibody Drug Production
February 10, 2026
News + PR
Wheeler Bio Announces Oversubscribed Series A-1, Plans for Expansion and Continued Growth
March 20, 2025
News + PR
Wheeler Bio Appoints Industry Veteran Patrick Lucy as Chief Executive Officer
October 9, 2024